p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 901–1,000 of 1,000
Daxx-like Protein of Drosophila Interacts with Dmp53 and Affects Longevity and Ark mRNA Level
Bodai, L., Pardi, N., Újfaludi, Z., Bereczki, O., Komonyi, O., Bálint, É., & Boros, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705547200 · Cited by 19
Engineering cancer resistance in mice
Klatt, P., & Serrano, M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg057 · Cited by 16
Aging and p53: getting it straight A commentary on a recent paper by Gentry and Venkatachalam
Vijg, J., & Hasty, P. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00179.x · Cited by 16
Flores, E. R., & Lozano, G. (2012) · Genes & Development · doi:10.1101/gad.202648.112 · Cited by 17
“Many of the premature aging phenotypes observed in the TAp73 / mice are reminiscent of those identified in TAp63 / mice (Su et al. 2009) and in one p53 mutant model (Tyner et al. 2002).”
BackgroundFu, S., Hu, J., Chen, X., Li, B., Shun, H., Deng, J., Zhang, Y., Yao, Y., & Zhao, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.658908 · Cited by 15
“For example, mutant SNP rs189037 in ATM gene or consistently high activity of P53 results in abnormal cardiac structure or premature senescence of individuals (19).”
BackgroundTAK1 Inhibition Accelerates Cellular Senescence of Retinal Pigment Epithelial Cells
Dvashi, Z., Green, Y. A., & Pollack, A. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14349 · Cited by 15
Smiles, W. J., & CAMERA, D. M. (2017) · Acta Physiologica · doi:10.1111/apha.13004 · Cited by 16
“Seminal studies in rodents demonstrated that overexpression of p53, despite conferring robust resistance to cancer, triggered premature ageing associated with pathological deterioration of tissues and organs, including skeletal muscle.(4,5) In contrast, a rodent model generated to carry p53-transgenic alleles and 2 Re…”
BackgroundAging and aging-associated diseases: a microRNA-based endocrine regulation hypothesis
Umansky, S. R. (2018) · Aging · doi:10.18632/aging.101612 · Cited by 16
“At least one study, which demonstrated degenerative processes and early symptoms of aging in mice with hyperactive p53 alleles, supported this idea [27].”
ResultPremature aging and cancer development in transgenic mice lacking functional CYLD
Alameda, J. P., Ramírez, Á., García-Fernández, R. A., Navarro, M., Page, A., Segovia, J. C., Sánchez‐Domínguez, R., Suárez-Cabrera, C., Paramio, J. M., Bravo, A., et al. (2019) · Aging · doi:10.18632/aging.101732 · Cited by 16
The Dynamic Partnership of Polycomb and Trithorax in Brain Development and Diseases
Kuehner, J. N., & Yao, B. (2019) · Epigenomes · doi:10.3390/epigenomes3030017 · Cited by 15
A phylogenetic review of cancer resistance highlights evolutionary solutions to Peto’s Paradox
Nery, M. F., Rennó, M., Picorelli, A., & Ramos, E. K. S. (2022) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2022-0133 · Cited by 20
“However, if the additional copies are constitutively expressed, this protection has the cost of an accelerated rate of aging (Tyner et al., 2002).”
den Reijer, P. M., Maier, A. B., Westendorp, R. G. J., & van Heemst, D. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.12.006 · Cited by 18
“On the other hand, mutant mice having constitutively activated p53 not only show enhanced resistance to spontaneous tumors but also an early onset of diverse aging phenotypes, including general loss of cellularity and reduced longevity (Donehower, 2002; Tyner et al., 2002; Maier et al., 2004).”
Cancer and aging: The molecular pathways
Bassi, P., & Sacco, E. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.07.013 · Cited by 20
Are cancer and ageing different sides of the same coin?
Pawelec, G., & Solana, R. (2008) · EMBO Reports · doi:10.1038/embor.2008.12 · Cited by 15
Kim, H., Lee, S. H., Lee, M.-N., Oh, G. T., Choi, K., & Choi, E. Y. (2013) · Oncotarget · doi:10.18632/oncotarget.1318 · Cited by 15
“For example, p53 is implicated in suppression of epigenetic silencing of many non-coding RNAs [33], suppression of aging [34-36], maintenance of a differentiated cellular state [37], and inhibition of oncogenic metabolism [38].”
Polypeptide Components of Telomere Nucleoprotein Complex
Kuimov, A. N. (2004) · Biochemistry (Moscow) · doi:10.1023/b:biry.0000018941.81962.1c · Cited by 17
Priami, C., Montariello, D., de Michele, G., Ruscitto, F., Polazzi, A., Ronzoni, S., Bertalot, G., Binelli, G., Gambino, V., Luzi, L., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01029-5 · Cited by 14
Franklin, D. A., Liu, S., Jin, A., Cui, P., Guo, Z., Arend, K. C., Moorman, N. J., He, S., Wang, G. G., Wan, Y. Y., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102739 · Cited by 17
Circulating progenitor cells and outcomes in patients with coronary artery disease
Dhindsa, D. S., Desai, S., Jin, Q., Sandesara, P. B., Mehta, A., Liu, C., Tahhan, A. S., Nayak, A., Ejaz, K., Hooda, A., et al. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.11.047 · Cited by 13
Links between telomere dysfunction and hallmarks of aging
Li, S., Liu, Z., Zhang, J., & Li, L. (2023) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2023.503617 · Cited by 16
SIRT-ain relief from age-inducing stress
Zhang, D., Liu, Y., & Chen, D. (2011) · Aging · doi:10.18632/aging.100283 · Cited by 14
Genomic Stability in Stem Cells
Riz, I., & Hawley, R. G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-227-8_6 · Cited by 15
“Mice carrying one copy of this truncated protein (p53+/m) developed a premature aging phenotype that included decreased proliferative and homing capacity of HSCs, reduced longevity, organ mass and cellularity, and heightened tumor resistance compared with their wild-type counterparts [59].”
BackgroundEvolutionary Adaptations to Risk of Cancer: Evidence From Cancer Resistance in Elephants
Greaves, M. F., & Ermini, L. (2015) · JAMA · doi:10.1001/jama.2015.13153 · Cited by 16
It's all about balance: p53 and aging
Biteau, B., & Jasper, H. (2009) · Aging · doi:10.18632/aging.100102 · Cited by 16
“Yet increasing p53 activity can have pleiotropic consequences: such interventions generally prevent cancer, increasing lifespan in some cases, but can also cause accelerated aging in others [6-11].”
BackgroundNovel biomarker profiles in experimental aged maternal mice with hypertensive disorders of pregnancy
Furuya, K., Kumasawa, K., Nakamura, H., Nishimori, K., & Kimura, T. (2018) · Hypertension Research · doi:10.1038/s41440-018-0092-7 · Cited by 16
Zebrafish Models for Skeletal Muscle Senescence: Lessons from Cell Cultures and Rodent Models
Ichii, S., Matsuoka, I., Okazaki, F., & Shimada, Y. (2022) · Molecules · doi:10.3390/molecules27238625 · Cited by 15
“Therefore, senescence is reported to be accelerated in Tp53−/m mice [64], and the knockout of tp53 in zebrafish is predicted to partially affect the skeletal muscle aging pathway.”
BackgroundSnoN in regulation of embryonic development and tissue morphogenesis
Zhu, Q., & Luo, K. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.005 · Cited by 16
“regenerative capacity [47], similar to that found in mice expressing an active p53 [71].”
BackgroundGesing, A., Masternak, M. M., Lewiñski, A., Karbownik‐Lewińska, M., Kopchick, J. J., & Bartke, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls231 · Cited by 14
“p53, apart from its well-known role as a “guardian of the genome,” is said to be a mediator of senescence and a contributor to aging (66,67).”
Backgroundp53 Pathway Alterations in Brain Tumors
Yin, S., & Meir, E. G. V. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_14 · Cited by 15
Oxidative Stress as a Risk Factor of Osteoporotic Model Induced by Vitamin A in Rats
Fahmy, S. R., & Soliman, A. M. (2009) · AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES · Cited by 15
Functional significance of MHC variation in mate choice, reproductive outcome, and disease risk
Loisel, D. A., Alberts, S. C., & Ober, C. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0008 · Cited by 15
Christensen, K., Pedersen, J. K., Hjelmborg, J., Vaupel, J. W., Stevnsner, T., Holm, N. V., & Skytthe, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls087 · Cited by 13
“In particular, p53 mutant mice with augmented p53 activity that display early aging sign and at the same time enhance the resistance to spontaneous tumors compared with wild types (7) have promoted the “better cancer protection–accelerated aging” hypothesis.”
BackgroundThe Yin-Yang of DNA Damage Response: Roles in Tumorigenesis and Cellular Senescence
Li, X., Xu, H., Chong-an, X., Lin, M., Song, X., Yi, F., Feng, Y., Coughlan, K. A., Cho, W., Kim, S. W., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022431 · Cited by 20
“The overall high p53 activity in p53 mice was attributed to the stabilization and enhancement of the p53 by the m allele product [69].”
BackgroundRadiation Risk Prediction and Genetics: The Influence of the TP53 Gene in vivo
Mitchel, R. E. J. (2005) · Dose-Response · doi:10.2203/dose-response.003.04.007 · Cited by 13
“Animals with TP53 defects are cancer prone (Harvey et al. 1993) but mice with constitutively activated TP53 are almost cancer free (Tyner et al. 2002).”
BackgroundResultThe Search for Biomarkers of Aging: Next Stop INK4a/ARF Locus
Dimri, G. P. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.44.pe40 · Cited by 15
Acute psychological stress-induced progenitor cell mobilization and cardiovascular events
Almuwaqqat, Z., Wittbrodt, M. T., Moazzami, K., Garcia, M. C., Lima, B. B., Martini, A., Sullivan, S. M., Nye, J. A., Pearce, B. D., Shah, A. J., et al. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111412 · Cited by 12
Ageing-associated phenotypes in mice
Xie, K., & Ehninger, D. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111852 · Cited by 14
Kirby, T. J., Zahr, H. C., Fong, E. H. H., & Lammerding, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01998-1 · Cited by 14
“This is despite the fact that in skeletal muscle, chronic activation of p53 can lead to muscle wasting [30] and p53 has been implicated in other skeletal muscle diseases [31 – 33].”
BackgroundMethodTP53 Arg72Pro, mortality after cancer, and all-cause mortality in 105,200 individuals
Kodal, J. B., Vedel‐Krogh, S., Kobylecki, C. J., Nordestgaard, B. G., & Bojesen, S. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-00427-x · Cited by 14
Adawi, M. M., Pastukh, N., Saaida, G., Sirchan, R., Watad, ., & Blum, A. (2018) · QJM · doi:10.1093/qjmed/hcy099 · Cited by 16
Possibility of inducing tumor cell senescence during therapy (Review)
Wang, G., Cheng, X., Zhang, J., Liao, Y., Jia, Y., & Qing, C. (2021) · Oncology Letters · doi:10.3892/ol.2021.12757 · Cited by 19
“In one study, mice that were genetically engineered to express altered isoforms of p53 with increased activity were shown to be resistant to cancer (84).”
BackgroundAdipose MDM2 regulates systemic insulin sensitivity
Hallenborg, P., Jensen, B. A. H., Fjære, E., Petersen, R. K., Belmaáti, M.-S., Rasmussen, S. S., Gunnarsson, J. P., Lauritzen, P., Cheng, K. K. Y., Hermansson, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01240-3 · Cited by 15
Paccosi, E., Balajee, A. S., & Proietti‐De‐Santis, L. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.960662 · Cited by 16
“A complex network of feedback loop mechanisms controls the action of this protein (Tyner et al., 2002; Brown et al., 2009).”
BackgroundOsawa, T., Atsumi, Y., Sugihara, E., Saya, H., Kanno, M., Tashiro, F., Masutani, M., & Yoshioka, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.091 · Cited by 14
Creation and preliminary characterization of a Tp53 knockout rat
McCoy, A., Besch-Williford, C. L., Franklin, C. L., Weinstein, E. J., & Cui, X. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009704 · Cited by 15
“S1B).”
BackgroundThe dichotomy of p53 regulation by noncoding RNAs
Deng, Q., Becker, L., Ma, X., Zhong, X., Young, K. H., Ramos, K. S., & Li, Y. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju017 · Cited by 17
“Second, p53 deficiency in mice leads to earlier onset of tumorigenesis and significantly shortens their life span (Donehower and Lozano, 2009), yet hyperactive mutant p53 and extra copies of p53 shorten life span in mice (Tyner et al., 2002; Maier et al., 2004).”
BackgroundInteractions of Pri-miRNA-34b/c and TP53 Polymorphisms on the Risk of Osteoporosis
Fu, J., Sun, R., Li, J., Li, Q., Chen, G., & Fu, W. (2016) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2015.0282 · Cited by 13
“The p53 protein is a tumor suppressor that is activated by a variety of stressors to induce apoptosis, cell cycle arrest, or senescence, and may also be involved in regulating aging (Tyner et al., 2002).”
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo
Comiskey, D. F., Jacob, A. G., Sanford, B. L., Montes, M., Goodwin, A., Steiner, H. E., Matsa, E., Tapia-Santos, A. S., Bebee, T. W., Grieves, J. L., et al. (2017) · Oncogene · doi:10.1038/onc.2017.282 · Cited by 16
“…is expressed in a p53 heterozygous null background we demonstrated a shift in tumor spectrum from osteosarcoma [a common neoplasm for p53 +/− mice (73)] to RMS. Patient RMS tumors presenting with MDM2-ALT1 typically retain the wild-type p53 alleles and do not present with overt mutations (33).”
Divergent regulation of lncRNA expression by ischemia in adult and aging mice
Kaucsár, T., Róka, B., Tod, P., Do, P. T., Hegedüs, Z., Szénási, G., & Hamar, P. (2021) · GeroScience · doi:10.1007/s11357-021-00460-9 · Cited by 13
Will the real aging Sirtuin please stand up?
Liao, C., & Kennedy, B. K. (2012) · Cell Research · doi:10.1038/cr.2012.62 · Cited by 13
Tipping the Balance toward Longevity
Antebi, A. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00068-1 · Cited by 12
Overexpression of p73 causes apoptosis in vascular smooth muscle cells
Davis, B. B., Dong, Y., & Weiss, R. H. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00211.2002 · Cited by 12
“Furthermore, supporting this gene as a potential gene therapeutic agent, p73 is assumed to replace or enhance the p53 protective role in p53-lacking cells (7), and there are now serious concerns regarding augmentation of p53 wild-type activity in mice (30).”
BackgroundTelomeres and Mitochondrial Function
Finkel, T. (2011) · Circulation Research · doi:10.1161/res.0b013e31821bc2d8 · Cited by 16
“Furthermore, past studies had shown that animal models exhibiting constitutively activated p53 are often characterized by a phenotype consistent with accelerated aging.(4,5) Using both genetic and biochemical approaches, the authors demonstrated that telomere dysfunction activated p53, and once activated, p53 was an i…”
BackgroundTognocchi, M., Conte, M., Testai, L., Martucci, M., Serra, A., Salvioli, S., Calderone, V., Mele, M. L., & Conte, G. (2022) · Foods · doi:10.3390/foods11030398 · Cited by 13
“Studies have shown that mice with high TRP53 activity are resistant to cancer but show signs of accelerated aging and die prematurely [49,50].”
Background“Super p53” Mice Display Retinal Astroglial Changes
Salazar, J. J., Gallego‐Pinazo, R., de Hoz, R., Pinazo-Duran, M. D., Rojas, B., Ramirez, A. I., Serrano, M., & Ramirez, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065446 · Cited by 13
“It has been proposed that an increase in p53 functionality, while beneficial to prevent tumour development, can be detrimental to long-term viability because it may accelerate the ageing process [59].”
BackgroundRNA interference in human foreskin fibroblasts within the three-dimensional collagen matrix
Carlson, M. A., Prall, A. K., & Gums, J. J. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9561-z · Cited by 12
“has direct relevance to wound healing [8, 9].”
Candidate Genes That Affect Aging Through Protein Homeostasis
Argon, Y., & Gidalevitz, T. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2404-2_2 · Cited by 15
Balancing and Differentiating p53 Activities toward Longevity and No Cancer?
Horikawa, I. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-3080 · Cited by 14
Systematic Analysis of mRNAs and ncRNAs in BMSCs of Senile Osteoporosis Patients
Geng, Y., Chen, J., Chang, C., Zhang, Y., Duan, L., Zhu, W., Mou, L., Xiong, J., & Wang, D. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.776984 · Cited by 12
“In addition, “p53 signaling pathway” and “Hedgehog signaling pathway” were significantly enriched, which have also been suggested to play important roles in osteogenesis (Tyner et al., 2002; Onodera et al., 2020) (Figure 6C).”
BackgroundBreaking the aging epigenetic barrier
Sikder, S., Arunkumar, G., Melters, D. P., & Dalal, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.943519 · Cited by 12
“These data demonstrated high tumor occurrence in p53 knockout mice (Tyner et al., 2002).”
BackgroundShibuya, S., Nojiri, H., Morikawa, D., Koyama, H., & Shimizu, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405933-7.00014-7 · Cited by 12
Time-course Transcriptional Profiling of Human Amniotic Fluid-derived Stem Cells Using Microarray
Kim, Y. W., Kim, H., Bae, S.-M., Kim, Y., Shin, J.-C., Chun, H. J., Rhie, J., Kim, J.-Y., Kim, H., & Ahn, W. S. (2010) · Cancer Research and Treatment · doi:10.4143/crt.2010.42.2.82 · Cited by 12
“Conversely, mice with activated p53 display signs of premature aging (7).”
BackgroundThe protective effect of PFTα on alcohol-induced osteonecrosis of the femoral head
Chen, Y., Zhu, D., Yin, J., Yin, W., Zhang, Y.-L., Ding, H., Yu, X., Mei, J., Gao, Y., & Zhang, C. (2017) · Oncotarget · doi:10.18632/oncotarget.19160 · Cited by 12
Homeostasis Research Model Based on Yin-Yang Theory: Five Examples
Wang, D., & Qu, M. (2021) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-2861-4 · Cited by 12
“Tyner, et al((18)) produced mice carrying the mutant p53 allele.”
BackgroundPaccosi, E., & Proietti‐De‐Santis, L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111466 · Cited by 13
Methods for screening tumors for p53 status and therapeutic exploitation
Tullo, A., D’Erchia, A. M., & Sbisà, E. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.3.289 · Cited by 12
DNA repair, insulin signaling and sirtuins: at the crossroads between cancer and aging
Mostoslavsky, R. (2008) · Frontiers in bioscience · doi:10.2741/3203 · Cited by 13
“In this regard, two groups have independently found that mice expressing an N-terminally truncated form of p53 exhibit signs of premature aging (39, 40).”
BackgroundPUMA Kills Stem Cells to Stall Cancer?
Yu, J. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.14 · Cited by 13
“Too much of it can potentially lead to stem cell exhaustion and premature aging, which was modeled by the “super p53” mice that resist cancer development but age prematurely depending on the dosage and genetic background (58, 59).”
BackgroundChaturvedi, V., Bacon, P. E., Bodner, B. K., & Nickoloff, B. J. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23514.x · Cited by 12
“A recent report in which a constitutively activated p53 mutation was introduced into mice conferred a phenotype characterized by accelerated senescence of several organ systems including the skin”
BackgroundGuidelines for describing mouse skeletal phenotype
Boskey, A. L., Wright, T. M., & van der Meulen, M. C. H. (2002) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(02)00102-x · Cited by 12
Human genetic variation of medical significance
Kídd, K. K., & Kidd, J. R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0005 · Cited by 11
Longevity regulation in flies: A role for p53
Donehower, L. A. (2008) · Aging · doi:10.18632/aging.100010 · Cited by 17
Self-citationLive Fast, Die Young: New Lessons in Mammalian Longevity
Cox, L. S. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0894 · Cited by 14
“…of the tumor suppressor p53 in organisms such as flies that do not succumb to cancer leads to lifespan extension, 33 whereas p53 overactivity results in premature aging of mice, 34 at least in part by inducing expression of p21 CDKN1 required for maintaining cell cycle arrest in senescence.”
Imai, R., Asai, K., Hanai, J., & Takenaka, M. (2015) · Aging · doi:10.18632/aging.100779 · Cited by 11
“Prematurely aged mice exhibit early aging-like appearance phenotypes, including increased hair loss, lordokyphosis of the spine, a shortened lifespan and growth retardation, compared to wild-type mice [24-28].”
BackgroundRoles and mechanisms of histone methylation in vascular aging and related diseases
Ji, Y., Chen, Z., & Cai, J. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01842-y · Cited by 13
“Tumor suppressors such as p53, p21, and p16 play crucial roles in this process by regulating the cell cycle and promoting apoptosis [41, 42].”
Stratton, S. A., & Barton, M. C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.009 · Cited by 11
“Taken together with indirect regulation of inflammation, by virtue of p53-mediated suppression of NF-jB activation [24], these p53-regulated pathways may add to the complex picture of p53 functions in aging [25].”
BackgroundGenetics of proliferative aging
Zucchero, T. M., & Ahmed, S. C. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.057 · Cited by 10
“Indeed, hyperactive p53 has been shown to confer premature proliferative aging phenotypes in the mouse (Tyner et al., 2002), whereas expression of the p16/RB inhibitor BMI-1 can extend the replicative lifespans of both rodent and human cells that succumb to non-telomeric forms of oxidative damage…”
BackgroundImmune System and Ageing in the Dog: Possible Consequences and Control Strategies
Dall’Ara, P. (2003) · Veterinary Research Communications · doi:10.1023/b:verc.0000014214.57325.60 · Cited by 13
“Surprisingly, ageing may be a side effect of the natural safeguards that protect us from cancer: in other words, the price of tumour suppression (Ferbeyre and Lowe, 2002; Tyner et al., 2002 ).”
BackgroundPathological Role of Adipose Tissue Dysfunction in Cardio-Metabolic Disorders
Shimizu, I., Yoshida, Y., & Minamino, T. (2015) · International Heart Journal · doi:10.1536/ihj.14-401 · Cited by 11
Egr-1 and Hipk2 are required for the TrkA to p75NTR switch that occurs downstream of IGF1-R
Li, H., Costantini, C., Scrable, H. J., Weindruch, R. H., & Puglielli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.015 · Cited by 14
“In contrast, hyperactivation of IGF1-R signaling in p44+/+ [27], p53+/m [41], and Zmpste24−/− [43] mice accelerates the progression of aging and shortens the maximum lifespan.”
BackgroundConcurrent expression of heme oxygenase-1 and p53 in human retinal pigment epithelial cell line
Lee, S. Y., Jo, H. J., Kim, K. M., Song, J. D., Chung, H., & Park, Y. C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.081 · Cited by 11
Dementia and Cancer: A Review of the Literature and Current Practice
Solomons, L. C., Solomons, J., & Gosney, M. (2013) · Aging Health · doi:10.2217/ahe.13.27 · Cited by 12
Pietro, F. D., Dato, S., Carpi, F. M., Corneveaux, J. J., Serfaustini, S., Maoloni, S., Mignini, F., Huentelman, M. J., Passarino, G., & Napolioni, V. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls223 · Cited by 13
“Gain-of-function TP53 mutations have been linked not only to a reduced frequency of tumors but also to accelerated aging and premature death in mice (3).”
BackgroundAge‑related changes in mineralocorticoid receptors in rat hearts
Hu, D., Dong, R., Zhang, Y., Yang, Y., Chen, Z., Tang, Y., Fu, M., Xu, X., & Tu, L. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11260 · Cited by 11
“The tumor suppressor p53, an aging marker, and TGF-β, a marker of extracellular matrix synthesis and degradation, were examined in rat hearts by western blot analysis (19,20).”
BackgroundThe Genetics of Aging – Implications for Pharmacogenomics
Perls, T. T., & Puca, A. A. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.4.469 · Cited by 14
Yoshioka, K., Atsumi, Y., Fukuda, H., Masutani, M., & Teraoka, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13056492 · Cited by 12
“However, unlike mice that show functional Arf and p53 regulation, transgenic mice with hyper-active p53 with no MDM2-binding site show a reduced lifespan and premature aging [69–71].”
Backgroundp53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
Römer, L., Klein, C., Dehner, A., Kessler, H., & Büchner, J. (2006) · Angewandte Chemie · doi:10.1002/ange.200600611 · Cited by 16
The effects of proliferation and DNA damage on hematopoietic stem cell function determine aging
Khurana, S. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24388 · Cited by 11
Aspects biologiques de la longévité et du vieillissement
Kappeler, L., & Epelbaum, J. (2005) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/s0398-7620(05)84600-0 · Cited by 16
Role of p53 in Cisplatin-Induced Myotube Atrophy
Matsumoto, C., Sekine, H., Zhang, N., Mogami, S., Fujitsuka, N., & Takeda, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119176 · Cited by 11
“Studies have also shown that p53 overexpression leads to the emergence of senescent traits and muscle atrophy [33,37], and muscle-specific p53-knockout (KO) mice were partially resistant to immobilization-induced skeletal muscle atrophy [33].”
BackgroundHasan, T., Pasala, A. R., Hassan, D., Hanotaux, J., Allan, D., & Maganti, H. B. (2024) · Current Oncology · doi:10.3390/curroncol31020044 · Cited by 11
“Moreover, mice overexpressing truncated isoforms of p53 (DNp53) or the short isoform of p53 (p44) exhibited accelerated aging and reduced HSC engraftment capabilities [82,83].”
BackgroundCombined Usage of Stem Cells in End‐Stage Heart Failure Therapies
Wang, X., Zachman, A. L., Haglund, N. A., Maltais, S., & Sung, H. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24782 · Cited by 10
“Finally, in subjects with high cardiovascular risk, EPCs were found to become prematurely senescent, coincidingwith observations in animal studies that stem cell exhaustion limits longevity [Geiger and Van Zant, 2002; Tyner et al., 2002].”
BackgroundAging and oxidative stress: A new look at old bone
Almeida, M. (2010) · IBMS BoneKEy · doi:10.1138/20100467 · Cited by 11
“In line with this, mouse genetic studies have revealed that p53 negatively regulates osteoblastogenesis and bone formation (21;28;29).”
BackgroundEvaluation of Genetic Enhancement: Will Human Wisdom Properly Acknowledge the Value of Evolution?
Coors, M. E., & Hunter, L. (2005) · The American Journal of Bioethics · doi:10.1080/15265160591002683 · Cited by 11
Singhal, S. S., Garg, R., Horne, D. A., Singhal, S., Awasthi, S., & Salgia, R. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188803 · Cited by 10
Bolcaen, J., Engelbrecht, M., van Vuuren, A. J., Xanthene, M., Nair, S., Randall, F., Walter, T., Burger, W., Rahiman, F., Rahiman, F., et al. (2023) · Animals · doi:10.3390/ani13142353 · Cited by 12
“Collagenase digestion has been successful for the establishment of primary cell cultures of the Asian elephant, Jaguar (Panthera onca) and non-human primates from skin biopsies [10,17,33].”
BackgroundFarhud, D., Asghari, M., & Sadighi, H. (2008) · Iranian Journal of Public Health · Cited by 69
Introducing Evolutionary Thinking For Medicine
Stearns, S. C., Nesse, R. M., & Haig, D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0001 · Cited by 18
The Role of Glycolysis in Cellular Immortalization
Kondoh, H. (2009) · Cellular Respiration and Carcinogenesis · doi:10.1007/978-1-59745-435-3_7 · Cited by 4
“in vivo[ 29 ] (Fig. 4). One possible interpretation would be that one of the major targets of p53 involved in senescence induction impacts metabolic regulation, which renders cells sensitive to oxidative stress.”
Background(2002) · PubMed · Cited by 156
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.